CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Breast Cancer

RESEARCH REPORT 

Eat Your Fruits and Veggies! Lower Breast Cancer Risk Associated With Higher Carotenoid Levels

By Anna Azvolinsky, PhD1 | December 14, 2012
1Freelance Science Writer and Cancer Network Contributor. Follow Her on Twitter

Women who have higher levels of pigments found in fruits and vegetables called carotenoids may have a lower risk of breast cancer. This inverse relationship was found to be particularly strong for more lean women, those with ER-negative tumors, and current smokers. Women who smoke or consume alcohol(Drug information on alcohol) may gain more benefit from consumption of carotenoids, according to the authors. These results of a pooled analysis of prospective trials published in the Journal of the National Cancer Institute.

“The inverse associations we observed among ER-negative tumors highlight carotenoids as one of the first modifiable risk factors for this poor prognosis tumor type,” state the authors. For ER-positive breast cancers, hormone-level effects may mask the beneficial effects of carotenoids.

A. Heather Eliassen, ScD, of the department of medicine at Brigham & Women's Hospital and Harvard Medical School, and colleagues included more than 3,000 subjects and almost 4,000 control subjects among worldwide publications on serum and plasma carotenoid levels and breast cancer. The analysis includes 80% of the published prospective data.

Circulating levels of carotenoids are seen as a better way to understand the effect of dietary carotenoids without the high inaccuracies of subject-reported diet, the spectrum of carotenoid levels from different food sources, and varying levels of nutrient absorption among individuals. On their own, the studies showed statistically significant or a suggested inverse relationship between breast cancer risk and levels of at least one carotenoid.

The reported carotenoid levels of trial participants were recalibrated to a common benchmark in order to compare levels between different trials. The levels of α-carotene, β-carotene, lycopene, β-cryptoxanthin, lutein, and zeaxanthin, the most common carotenoids, accounting for the vast majority of circulating carotenoids in our body from the foods we eat.

Unadjusted analysis showed a significant inverse association between lycopene levels and breast cancer risk (P = .05). Factors that appeared to contribute to this association included body mass index (BMS), smoking, and menopausal status. When incorporating these factors, levels of each individual carotenoid, except β-cryptoxanthin, was inversely associated with breast cancer risk.

ER-negative breast tumors had the strongest, and statistically significant correlation with carotenoid levels. An association of both α-carotene and β-carotene, and ER-negative tumors was statistically significant (P = .04 and P = .001, respectively). Neither tumor size nor involvement of nodes correlated with breast cancer risk and carotenoid levels. The recent Dietary Approaches to Stop Hypertension study also recently showed a reciprocal relationship of fruit and vegetable consumption and ER-negative status but not ER-positive status.

The authors assessed whether the role of lifestyle factors including alcohol consumption, BMI menopausal status, postmenopausal hormone use, smoking status, and diagnosis affected whether carotenoids could influence breast cancer risk. Two associates appeared to be important. A statistically significant inverse interaction between total carotenoids and breast cancer risk was found for current smokers, regardless of the ER status of the breast tumor. The association also varied by BMI. Stronger inverse associations with breast cancer risk were seen for more lean women with a BMI of 25 or lower.

Carotenoids are organic pigments found in fruits and vegetables that range in color from yellow to red. α-carotene, β-carotene, lycopene, β-cryptoxanthin are converted by the body to vitamin A. The color of a carotenoid is related to their structure and type. Orange and yellow fruits and vegetables such as carrots and apricots tend to have high vitamin A activity because they contain β-carotene, the most well-known carotenoid, while lycopene is orange-red and found in tomatoes and watermelon.

Both epidemiological and laboratory studies have hinted that carotenoids have anticancer properties, including anti-oxidation properties. Meta-analyses of dietary intake have shown a lower risk of breast cancer for those who consume higher levels of fruit and vegetables. In vitro studies have demonstrated that carotenoids can decrease proliferation of breast cancer cells. Several epidemiological studies have also shown that men who consume a diet high in lycopene have a lower probability of developing prostate cancer compared to men who consume less lycopene.

“A diet high in carotenoid-rich fruits and vegetables offers many health benefits, including a possible reduced risk of breast cancer,” conclude the authors.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Diana Chalmers | January 03, 2013 11:59 AM EST

Not too sure of food related protection!! My support is on the genetic teams, but do families eat similar foods and so get similar protection or diseases??






 
RELATED CONTENT

50 Shades of Pink—And Why It Helps to Know the Difference
May 17, 2013
It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
ONCOLOGY,  May 13, 2013
HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit From Trastuzumab Maintenance
May 7, 2013
PIK3CA Mutations Negatively Affect Survival in Trastuzumab-Treated HER2-Positive Breast Cancer
May 6, 2013
US Task Force Recommends Breast Cancer Medications for High-Risk Women
April 24, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Breast Cancer
Evidence on Breast Cancer
Guidelines on Breast Cancer
Patient Education on Breast Cancer
Clinical Trials on Breast Cancer
Practical Articles on Breast Cancer
Research and Reviews on Breast Cancer
All "Breast Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy